These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17869524)

  • 1. The molecular pruning of a phosphoramidate peptidomimetic inhibitor of prostate-specific membrane antigen.
    Wu LY; Anderson MO; Toriyabe Y; Maung J; Campbell TY; Tajon C; Kazak M; Moser J; Berkman CE
    Bioorg Med Chem; 2007 Dec; 15(23):7434-43. PubMed ID: 17869524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoramidate derivatives of hydroxysteroids as inhibitors of prostate-specific membrane antigen.
    Wu LY; Do JC; Kazak M; Page H; Toriyabe Y; Anderson MO; Berkman CE
    Bioorg Med Chem Lett; 2008 Jan; 18(1):281-4. PubMed ID: 18023582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-Activity Relationship of (18)F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer.
    Dannoon S; Ganguly T; Cahaya H; Geruntho JJ; Galliher MS; Beyer SK; Choy CJ; Hopkins MR; Regan M; Blecha JE; Skultetyova L; Drake CR; Jivan S; Barinka C; Jones EF; Berkman CE; VanBrocklin HF
    J Med Chem; 2016 Jun; 59(12):5684-94. PubMed ID: 27228467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer.
    Ganguly T; Dannoon S; Hopkins MR; Murphy S; Cahaya H; Blecha JE; Jivan S; Drake CR; Barinka C; Jones EF; VanBrocklin HF; Berkman CE
    Nucl Med Biol; 2015 Oct; 42(10):780-7. PubMed ID: 26169882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities.
    Novakova Z; Cerny J; Choy CJ; Nedrow JR; Choi JK; Lubkowski J; Berkman CE; Barinka C
    FEBS J; 2016 Jan; 283(1):130-43. PubMed ID: 26460595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudoirreversible inhibition of prostate-specific membrane antigen by phosphoramidate peptidomimetics.
    Liu T; Toriyabe Y; Kazak M; Berkman CE
    Biochemistry; 2008 Dec; 47(48):12658-60. PubMed ID: 18983168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoramidate-based peptidomimetic inhibitors of membrane type-1 matrix metalloproteinase.
    Mendes DE; Wong-On-Wing A; Berkman CE
    J Enzyme Inhib Med Chem; 2016; 31(1):167-71. PubMed ID: 25815671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of constrained phosphoramidate inhibitors of prostate-specific membrane antigen.
    Ley CR; Beattie NR; Dannoon S; Regan M; VanBrocklin H; Berkman CE
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2536-9. PubMed ID: 25956413
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Choy CJ; Ling X; Geruntho JJ; Beyer SK; Latoche JD; Langton-Webster B; Anderson CJ; Berkman CE
    Theranostics; 2017; 7(7):1928-1939. PubMed ID: 28638478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Surface labeling and internalization by a fluorescent inhibitor of prostate-specific membrane antigen.
    Liu T; Wu LY; Kazak M; Berkman CE
    Prostate; 2008 Jun; 68(9):955-64. PubMed ID: 18361407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of tetrapeptide ligands as inhibitors of the Src SH2 domain.
    Nam NH; Pitts RL; Sun G; Sardari S; Tiemo A; Xie M; Yan B; Parang K
    Bioorg Med Chem; 2004 Feb; 12(4):779-87. PubMed ID: 14759738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-herpetic activity of phosphoramidate ProTides.
    Maiti M; Persoons L; Andrei G; Snoeck R; Balzarini J; Herdewijn P
    ChemMedChem; 2013 Jun; 8(6):985-93. PubMed ID: 23606629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential effective inhibitory compounds against Prostate Specific Membrane Antigen (PSMA): A molecular docking and molecular dynamics study.
    Nikfarjam Z; Bavi O; Amini SK
    Arch Biochem Biophys; 2021 Mar; 699():108747. PubMed ID: 33422503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate specificity of prostate-specific membrane antigen.
    Anderson MO; Wu LY; Santiago NM; Moser JM; Rowley JA; Bolstad ES; Berkman CE
    Bioorg Med Chem; 2007 Nov; 15(21):6678-86. PubMed ID: 17764959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs.
    Barinka C; Hlouchova K; Rovenska M; Majer P; Dauter M; Hin N; Ko YS; Tsukamoto T; Slusher BS; Konvalinka J; Lubkowski J
    J Mol Biol; 2008 Mar; 376(5):1438-50. PubMed ID: 18234225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of 2'-deoxy-2',2'-difluoro-5-halouridine phosphoramidate ProTides.
    Quintiliani M; Persoons L; Solaroli N; Karlsson A; Andrei G; Snoeck R; Balzarini J; McGuigan C
    Bioorg Med Chem; 2011 Jul; 19(14):4338-45. PubMed ID: 21696963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphoramidate protides of carbocyclic 2',3'-dideoxy-2',3'-didehydro-7-deazaadenosine with potent activity against HIV and HBV.
    Gudmundsson KS; Wang Z; Daluge SM; Johnson LC; Hazen R; Condreay LD; McGuigan C
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(12):1929-37. PubMed ID: 15628749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastereoselective synthesis of P-chirogenic phosphoramidate prodrugs of nucleoside analogues (ProTides) via copper catalysed reaction.
    Pertusati F; McGuigan C
    Chem Commun (Camb); 2015 May; 51(38):8070-3. PubMed ID: 25867944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of phosphoramide derivatives as urease inhibitors.
    Domínguez MJ; Sanmartín C; Font M; Palop JA; San Francisco S; Urrutia O; Houdusse F; García-Mina J
    J Agric Food Chem; 2008 May; 56(10):3721-31. PubMed ID: 18452297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cancer ProTides: tuning the activity of BVDU phosphoramidates related to thymectacin.
    McGuigan C; Thiery JC; Daverio F; Jiang WG; Davies G; Mason M
    Bioorg Med Chem; 2005 May; 13(9):3219-27. PubMed ID: 15809157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.